Doye & Chalmel Frères is a private trading firm specializing in biotech investments. We focus on opportunities tied to key catalysts. Our investment decisions are based upon our analysis of both the compound's overall properties as well as available clinical data. We engage in asymmetric opportunities poised for rapid and significant returns on capital.
One of our latest trades was a short position in Cassava Sciences, which has depreciated by -90.4% since the publication of the paper.
We are open to collaboration:
contact@doyechalmelfreres.com
Company Details
- Employees
- 3
- Address
- Brussels, Be
- Industry
- Investment Management
- NAICS
-
Other Financial Investment ActivitiesPortfolio ManagementAll Other Financial Investment ActivitiesTrust, Fiduciary, and Custody ActivitiesMiscellaneous Financial Investment Activities
- Keywords
- Finance, Biotech, Investment, Management.
- HQ
- Brussels
Doye & Chalmel Frères Questions
Doye & Chalmel Frères's LinkedIn profile is https://be.linkedin.com/company/doye-chalmel-fr%C3%A8res
Doye & Chalmel Frères has
3 employees.
View email and phone details for 3
employees at Doye & Chalmel Frères.
Doye & Chalmel Frères's industry is
Investment Management
Doye & Chalmel Frères's top competitors are
Dcf,
Brooker Consulting,
Cwm-Media,
Dcrm Sciences,
Amris Consulting,
Dcf - M&a Partners,
Dafna Capital Management, Llc,
Arboreal Capital,
Neuorphan,
Perms Direct.
Doye & Chalmel Frères's categories are Investment Management
